Standard BioTools Inc logo

Standard BioTools Inc

NAS:LAB (USA)  
$ 2.78 -0.12 (-4.12%) 10:08 PM EST
At Loss
Volume:
2.34M
Avg Vol (2M):
2.25M
Also Trade In:
Volume:
2.34M
At Loss
Avg Vol (2M):
2.25M

Business Description

Standard BioTools Inc logo
Standard BioTools Inc
NAICS : 334516 SIC : 3826
ISIN : US34385P1084
Description
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
Name Current Vs Industry Vs History
Cash-To-Debt 1.17
Equity-to-Asset -0.46
Debt-to-Equity -0.66
Debt-to-EBITDA -1.8
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.18
Distress
Grey
Safe
Beneish M-Score -2.85
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 47.17
9-Day RSI 53.21
14-Day RSI 55.35
6-1 Month Momentum % 65.43
12-1 Month Momentum % 50.56

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.45
Quick Ratio 1.26
Cash Ratio 1.05
Days Inventory 141.21
Days Sales Outstanding 57.06
Days Payable 47.72

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.5
Shareholder Yield % 1.64

Financials (Next Earnings Date:2024-05-09 Est.)

LAB's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:LAB

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Standard BioTools Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 106.34
EPS (TTM) ($) -0.95
Beta 1.62
Volatility % 76.64
14-Day RSI 55.35
14-Day ATR ($) 0.162286
20-Day SMA ($) 2.711
12-1 Month Momentum % 50.56
52-Week Range ($) 1.46 - 3.16
Shares Outstanding (Mil) 382.46

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Standard BioTools Inc Filings

Filing Date Document Date Form
No Filing Data

Standard BioTools Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Standard BioTools Inc Frequently Asked Questions

What is Standard BioTools Inc(LAB)'s stock price today?
The current price of LAB is $2.78. The 52 week high of LAB is $3.16 and 52 week low is $1.46.
When is next earnings date of Standard BioTools Inc(LAB)?
The next earnings date of Standard BioTools Inc(LAB) is 2024-05-09 Est..
Does Standard BioTools Inc(LAB) pay dividends? If so, how much?
Standard BioTools Inc(LAB) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1